Posters

Practice pattern for prevention of postsurgical endophthalmitis among ophthalmologists working in Egypt

Poster Details

First Author: D.Sobeih EGYPT

Co Author(s):                        

Abstract Details

Purpose:

Postoperative endophthalmitis is one of the most critical complications of ocular surgeries; it is an ophthalmic emergency that may cause a permanent loss of vision. Prophylaxis against postsurgical endophthalmitis is mandatory to reduce such risk. The purpose of the study is to investigate the variation in the practice pattern for prevention of infectious endophthalmitis among surgeons working in Mansoura city and compare the results to the ESCRS guidelines for prevention of postoperative endophthalmitis.

Setting:

The study was conducted among surgeons working in Mansoura. Ophthalmologists from university hospitals, the ministry of health, and private practice were invited to participate in the study and fill in the questionnaire.

Methods:

Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis was collected through an online survey that was sent to their emails and posted on scientific groups.

Results:

A total of 81 surgeons have responded the survey. The majority of the respondents (67%) used moxifloxacin as a prophylactic preoperative antibiotic for 4 or 5 times/day (70%). Povidone iodine was routinely used before surgery by 83% of participants. Intracameral antibiotics were not commonly used by surgeons (only 18%). The reason behind this low rate was proved to be the fear of toxicity followed by the cost. The most popular route of administration of the prophylactic antibiotic used by the end of surgery was mainly subconjunctival. Most surgeons used moxifloxacin antibiotic used after surgery (92%).

Conclusions:

The current survey-based study indicated a strong preference of moxifloxacin for preoperative and postoperative prophylaxis. International organizations and pharmaceutical companies need to spend more efforts to encourage more surgeons to use intracameral antibiotics.

Financial Disclosure:

None